Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 12239654

Compounds and methods for treating neurological and cardiovascular conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239692

Adeno-associated virus factor VIII vectors

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239709

Biodegradable lipids for the delivery of active agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239684

Modulators of complement activity

RA PHARMACEUTICALS, INC. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239677

Therapeutic bacteriophage compositions for treating Staphylococcus infection

Armata Pharmaceuticals, Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239729

TRPV3 agonists for the treatment of skin conditions

Soricimed Biopharma Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12240902

Anti-TREM2 antibodies and methods of use thereof

DENALI THERAPEUTICS INC. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239694

Methods and compositions for improved cognition

The Regents of the University of California · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12240917

Anti-complement C1s antibodies and uses thereof

Bioverativ USA Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12240846

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

Enliven Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12240852

Co-crystals, method and apparatus for forming the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12239712

Combination therapy for the treatment of liver disease

GALMED RESEARCH AND DEVELOPMENT LTD · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233241

Methods and systems to validate physiologic waveform reliability and uses thereof

The Regents of the University of California · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233105

Methods for storing and warming purified corticotropin compositions

ANI Pharmaceuticals, Inc. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233104

Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist

Nektar Therapeutics · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233106

C-type natriuretic peptide variants to treat skeletal dysplasia in children

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233092

MSC-NTF specific exosomes and use thereof

BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233124

Recombinant metapneumovirus f proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233090

Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19

The Regents of the University of California · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12233132

Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions inc

Serina Therapeutics, Inc. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12234230

Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

NURIX THERAPEUTICS, INC. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12234461

Targeted non-viral DNA insertions

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12234460

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12234474

Method to prevent the myelin abnormalites associated with arginase deficiency

The Regents of the University of California · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)